UBS analyst Michael Leuchten raised the price target on AstraZeneca (NASDAQ: AZN) to $4,925.00 (from $4,260.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE